In a recent LinkedIn post, Sharonkedar discusses the critical and often rapid progression of sepsis and highlights a significant development in diagnostic tools aimed at combating this life-threatening condition. Sharonkedar frames sepsis as a condition that can move with alarming speed, drawing a parallel to a race car accelerating from 0 to 200 in seconds.
The post underscores the severity of sepsis, noting its ability to affect even robust individuals, citing historical figures like Muhammad Ali and Jim Henson as examples. Sharonkedar emphasizes the long-standing challenge faced by medical professionals:
“Doctors have been ‘racing’ against the clock. Doing their best. But they have been working with limited rapid diagnostic tools to date.”
This highlights a crucial gap in timely and effective sepsis management. Sharonkedar expresses a shared desire for improvement among doctors, patients, and their families.
A New Era in Sepsis Diagnostics
Sharonkedar shares a message of hope, introducing a potential game-changer in sepsis diagnosis. The post details an interview with Dr. Tim Sweeney, CEO and Co-Founder of Inflammatix, Inc., a company dedicated to transforming sepsis diagnostics for years.
FDA Approval and Technological Advancement
A key piece of information shared by Sharonkedar is the recent FDA approval of Inflammatix’s rapid answer blood test, TriVerity, in 2025. This development is presented as a significant leap forward in the fight against sepsis. According to Sharonkedar, the test operates by measuring the expression of 29 immune response genes.
“The test measures the expression of 29 immune response genes and uses AI to generate three rapid scores: 1️⃣the likelihood of bacterial infection 2️⃣viral infection 3️⃣severe illness requiring critical care.”
This multi-faceted approach, powered by artificial intelligence, promises to provide clinicians with crucial information much faster than traditional methods. Sharonkedar credits the team at Inflammatix, Inc. for raising the standard in this critical area of healthcare.
The Impact of Rapid Diagnostics
Sharonkedar’s post implicitly argues that the availability of rapid and accurate diagnostic tools like TriVerity can significantly alter patient outcomes. By quickly identifying the likelihood of bacterial or viral infection, and assessing the severity of illness, clinicians can initiate appropriate treatment protocols much sooner.
“Sepsis can move just as fast.”
This quote, placed early in the post, serves to reinforce the urgency and the need for swift medical intervention. Sharonkedar’s coverage of Dr. Sweeney’s work suggests that this new technology directly addresses the limitations previously faced by healthcare providers.
Looking Ahead
The full details of the interview with Dr. Sweeney are expected to be available soon, as noted by Sharonkedar. The post concludes with a note of appreciation for the efforts of Inflammatix, Inc., framing their work as a vital contribution to human health. Sharonkedar’s thoughtful sharing of this news serves to inform a broader audience about promising innovations in medical diagnostics, particularly in the urgent battle against sepsis.
📝 About This Content
This article is based on insights shared by Sharonkedar on LinkedIn.
📅 Originally posted on June 1, 2026 | View original post on LinkedIn →